Medicare Enrolled
Dr. Rajjit Abrol, MD
Cardiovascular Disease · Plano, TX
Practice pattern: Electrophysiology & Remote— Practice combining electrophysiology and remote services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Abrol from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Abrol? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Abrol
Dr. Rajjit Abrol is a cardiovascular disease in Plano, TX, with 19 years in practice. Based on federal Medicare data, Dr. Abrol performed 7,038 Medicare services across 3,616 unique beneficiaries.
Between the years covered by Open Payments, Dr. Abrol received a total of $15,621 from 43 pharmaceutical and/or device companies across 353 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Abrol is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 8% volume in TX$ $15,621 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,038
Medicare services
Top 8% in TX for cardiovascular disease
3,616
Unique beneficiaries
$50
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~370 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Remote pacemaker/defibrillator monitoring, 90 days | 1,957 | $16 | $70 |
| Remote pacemaker monitoring, 90 days | 1,408 | $21 | $135 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 561 | $25 | $150 |
| Office visit, established patient (20-29 min) | 452 | $63 | $150 |
| Office visit, established patient (30-39 min) | 400 | $94 | $220 |
| Programming of dual lead pacemaker system | 331 | $55 | $126 |
| Electrocardiogram (EKG), 12-lead | 284 | $10 | $47 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 281 | $28 | $150 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 242 | $19 | $136 |
| New patient office visit (45-59 min) | 114 | $127 | $335 |
| Programming of multiple lead implantable defibrillator system | 91 | $71 | $186 |
| Evaluation of implantable heart and blood vessel monitoring system | 91 | $31 | $129 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 91 | $10 | $25 |
| Programming of single lead pacemaker system | 82 | $48 | $106 |
| Programming of dual lead implantable defibrillator system | 73 | $65 | $171 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 52 | $19 | $135 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 45 | $383 | $1,400 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 43 | $731 | $2,710 |
| Programming of multiple lead pacemaker system | 41 | $58 | $144 |
| Repair of left upper heart chamber with implant with review by radiologist | 38 | $604 | $1,650 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 33 | $237 | $1,020 |
| Initial hospital admission, moderate complexity | 31 | $95 | $280 |
| Hospital follow-up visit, moderate complexity | 28 | $58 | $150 |
| Hospital discharge day management, 30 minutes or less | 28 | $64 | $150 |
| New patient office visit (30-44 min) | 24 | $88 | $220 |
| Insertion of left lower heart electrode for pacemaker or defibrillator | 23 | $358 | $975 |
| Programming of single lead implantable defibrillator system | 23 | $47 | $143 |
| Insertion of heart rhythm monitor under skin | 22 | $66 | $300 |
| Removal and replacement of dual lead permanent pacemaker | 20 | $267 | $750 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 20 | $647 | $2,030 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 19 | $20 | $80 |
| Telephone medical discussion with physician, 11-20 minutes | 19 | $52 | $65 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 18 | $237 | $1,015 |
| Destruction of heart conduction tissue to create heart block | 15 | $389 | $1,245 |
| Insertion of implantable defibrillator system | 13 | $710 | $3,700 |
| Insertion of tube in upper and/or lower heart chambers to record and identify origin of abnormal heart rhythm | 13 | $211 | $585 |
| External shock to heart to regulate heart beat | 12 | $85 | $420 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
67.5% high complexity
0.0% medium
32.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$15,621
Total received (2018-2024)
Avg $2,232/year across 7 years
Top 23% in TX for cardiovascular disease
43
Companies
353
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,621 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$2,330
2023$1,977
2022$2,327
2021$1,313
2020$2,649
2019$1,841
2018$3,184
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic Vascular, Inc.
$3,898
Medtronic, Inc.
$3,290
Abbott Laboratories
$2,900
Biosense Webster, Inc.
$1,073
Boston Scientific Corporation
$801
Janssen Pharmaceuticals, Inc
$725
Impulse Dynamics (USA) Inc.
$331
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$200
Novartis Pharmaceuticals Corporation
$193
E.R. Squibb & Sons, L.L.C.
$187
HeartFlow, Inc.
$175
SANOFI-AVENTIS U.S. LLC
$173
Merck Sharp & Dohme LLC
$161
Amarin Pharma Inc.
$148
Amgen Inc.
$148
PFIZER INC.
$140
Tactile Systems Technology Inc
$110
ZOLL Respicardia, Inc.
$105
Boehringer Ingelheim Pharmaceuticals, Inc.
$98
Astellas Pharma US Inc
$73
Regeneron Healthcare Solutions, Inc.
$60
Edwards Lifesciences Corporation
$56
Potrero Medical, Inc.
$50
Innovation Technologies Inc
$47
Inspire Medical Systems, Inc.
$46
AngioDynamics, Inc.
$45
Esperion Therapeutics, Inc.
$39
Bardy Diagnostics, Inc.
$36
AstraZeneca Pharmaceuticals LP
$29
Kestra Medical Technology Services, Inc.
$29
PORTOLA PHARMACEUTICALS, INC.
$27
BOSTON SCIENTIFIC CORPORATION
$25
Recor Medical Inc
$25
CARDIVA MEDICAL, INC.
$25
iRhythm Technologies, Inc.
$23
CVRx, Inc.
$22
ConvaTec Inc.
$20
Novo Nordisk Inc
$19
Kowa Pharmaceuticals America, Inc.
$16
Baxter Healthcare
$15
Allergan Inc.
$14
MEDICOMP INC
$13
AltaThera Pharmaceuticals LLC
$10
Top 3 companies account for 64.6% of total payments
Associated products mentioned in payments ›
AGILIS · AMPERE · AMPLATZER AMULET · AMPLATZER Occluders · ANDEXXA · AQUACEL AG+ EXTRA · ARTIC-L 3D TI SPINAL SYSTEM WITH TIONIC TECHNOLOGY · ASSURITY · AURORA EV-ICD MRI SURESCAN · AVEIR · AZURE XT DR MRI SURESCAN · Advisa · Agilis NxT EP Introducer · Arctic Front · Armada 35 percutaneous catheter · Assure WCD · Assurity Pacemaker · Auryon Laser System 100-120 Vac · Azure · BRILINTA · BYSTOLIC · Barostim Neo System · CAMZYOS · CAPSUREFIX NOVUS MRI SURESCAN · CARTO 3 · CLARIA MRI QUAD CRT-D SURESCAN · COBALT DR MRI SURESCAN · CONFIRM RX · COREVALVE EVOLUT R · CROME DR MRI SURESCAN · CareLink · CareLink Express · Carnation Ambulatory Monitor · Carto 3 · Carto 3 System · Carto Smarttouch · CartoSound · Cobalt · Compia MRI · Confidense · Confirm Rx · Corlanor · CryoConsole · DIAMONDTEMP BIDIRECTIONAL ABLATION CATHETER · ELIQUIS · ENSITE · ENTRESTO · Edwards SAPIEN 3 Transcatheter Heart Valve · Ellipse ICD · Evera · FFRct · Flexitouch Plus · Fortify Assura · GALLANT · GENERAL THERAPIES · GENERAL TACHY · GENERAL THERAPIES · GENERAL - TACHY · GENERAL - THERAPIES · GENERAL THERAPIES · HYPERLIPIDEMIA - DISEASE · Hillrom - Carnation Ambulatory Monitor · INSPIRE · IRRISEPT · Intracardiac Echocardiography (ICE) · JARDIANCE · JOT DX · LEQVIO · LEXISCAN · LINQ II · LifeVest · Livalo · MICRA · MULTAQ · Merlin Connectivity and Remote · Micra · Mitra Clip system · NEXLETOL · OPTOWIRE · Optimizer · Ozempic · PARADISE RENAL DENERVATION SYSTEM · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Quadra Allure MP RF CRT Pacemkr · Quadra Assura CRT Defibrillator · Repatha · Resolute · Rhythmia Mapping System · SELECTSECURE · Sotalol Hydrochloride · TELEPATCH CARDIAC MONITOR · THERMOCOOL SMARTTOUCH · TYRX · VERQUVO · VYNDAQEL · Varithena Administration Pack · Vascepa · Visitag · WATCHMAN Access System · WATCHMAN FLX · XARELTO · ZIO Patch · remede System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $222 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
277
Per 100K population
24.8
County median income
$117,588
Nearest hospital
MEDICAL CITY PLANO
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Abrol is a electrophysiology & remote specialist, with above-average Medicare volume (top 8% in TX), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Abrol experienced with remote pacemaker/defibrillator monitoring, 90 days?
Based on Medicare claims data, Dr. Abrol performed 1,957 remote pacemaker/defibrillator monitoring, 90 days services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Abrol receive payments from pharmaceutical companies?
Yes. Dr. Abrol received a total of $15,621 from 43 companies across 353 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Abrol's costs compare to other cardiovascular diseases in Plano?
Dr. Abrol's average Medicare payment per service is $50. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Abrol) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Plano
Browse cardiovascular diseases in Plano ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in TX
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in TX
Which TX cardiovascular diseases receive the most from drug and device companies.
By company
Medtronic Vascular, Inc. Payments to Doctors
See all physicians who received payments from Medtronic Vascular, Inc..
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc..
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology